OTC Markets OTCPK - Delayed Quote ? USD Carl Zeiss Meditec AG (CZMWF) Follow Compare 66.50 0.00 (0.00%) At close: October 31 at 4:00 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Carl Zeiss Meditec (ETR:AFX) Will Be Hoping To Turn Its Returns On Capital Around There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and... Simply Wall St. ? 16 hours ago CZMWF 0.00% CZMWY -0.49% Is Carl Zeiss Meditec AG's (ETR:AFX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? Most readers would already be aware that Carl Zeiss Meditec's (ETR:AFX) stock increased significantly by 19% over the... Simply Wall St. ? 18 days ago CZMWF 0.00% CZMWY -0.49% ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions ZEISS Medical Technology will showcase digital enhancements and revolutionary surgical solutions at the American Academy of Ophthalmology (AAO) conference from Oct. 19-21, 2024, in Chicago. These innovations across cataract, corneal refractive, retina, and glaucoma workflows, offer new, enhanced paths to patient management and treatment, using a digitally connected environment to help advance the clinical workflow to support a higher level of personalized care. CNW Group ? 23 days ago CZMWF 0.00% CZMWY -0.49% ZEISS introduces its latest Robotic Visualisation System for neuro surgery At this year's Congress of Neurological Surgeons (CNS) in Houston, Texas, USA, ZEISS Medical Technology launches the KINEVO? 900 S. The latest Robotic Visualization System? is a further development of the successful ZEISS KINEVO 900 platform. With best digital visualization, collaborative assistant functions and connected intelligence, ZEISS KINEVO 900 S offers more clarity for complex surgical procedures in neurosurgery and other surgical disciplines. PR Newswire ? last month CZMWF 0.00% CZMWY -0.49% What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing? Carl Zeiss Meditec AG ( ETR:AFX ), is not the largest company out there, but it led the XTRA gainers with a relatively... Simply Wall St. ? last month CZMWF 0.00% CZMWY -0.49% ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens removal device, available in the U.S. ZEISS Medical Technology today announced the broad U.S. distribution of the MICOR? 700 from ZEISS, reinventing lens extraction with the first hand-held lens removal device with ultrasound-free operation, providing a sustainable solution with a low initial investment to help surgeons broaden their intraocular working space. Creating a gentler patient experience, the ZEISS MICOR 700 offers a revolutionary approach to lens removal, including patented crystalline lens extraction technology, a blunt PR Newswire ? last month CZMWF 0.00% CZMWY -0.49% ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow ZEISS Medical Technology will showcase digital innovations and its latest 3D visualization technology as part of the ZEISS Retina Workflow at the European Society of Retina Specialists (EURETINA) conference. The new solutions within the ZEISS Medical Ecosystem help improve the diagnosis and treatment of retinal patients using the latest integrated, digital technologies. PR Newswire ? last month CZMWF 0.00% CZMWY -0.49% The three-year loss for Carl Zeiss Meditec (ETR:AFX) shareholders likely driven by its shrinking earnings The truth is that if you invest for long enough, you're going to end up with some losing stocks. But long term Carl... Simply Wall St. ? last month CZMWF 0.00% CZMWY -0.49% ZEISS innovation paves way to more personalized patient care with cutting-edge AI technology and industry-leading surgical solutions ZEISS Medical Technology will showcase its latest cataract and corneal refractive workflow innovations at the European Society of Cataract and Refractive Surgeons (ESCRS) conference. ZEISS leads the industry as the first medical device manufacturer to offer treatment for hyperopia with lenticule extraction using SMILE? pro in the CE markets. ZEISS is also celebrating its latest refractive milestone of surpassing the 10 million mark for lenticule extraction procedures performed with ZEISS SMILE a PR Newswire ? 2 months ago CZMWF 0.00% CZMWY -0.49% Health Care Roundup: Market Talk Find insight on Straumann, Novo Nordisk, Novartis and more in the latest Market Talks covering the Health Care sector. The Wall Street Journal ? 2 months ago AZN AZNCF CZMWF 0.00% Private companies account for 59% of Carl Zeiss Meditec AG's (ETR:AFX) ownership, while institutions account for 22% Key Insights The considerable ownership by private companies in Carl Zeiss Meditec indicates that they collectively... Simply Wall St. ? 2 months ago CZMWF 0.00% CZMWY -0.49% An Intrinsic Calculation For Carl Zeiss Meditec AG (ETR:AFX) Suggests It's 37% Undervalued Key Insights Carl Zeiss Meditec's estimated fair value is €99.47 based on 2 Stage Free Cash Flow to Equity Current... Simply Wall St. ? 3 months ago CZMWF 0.00% CZMWY -0.49% ZEISS announces OCT technology enhancements to better support growing era of data-driven patient care ZEISS Medical Technology announced today that the CIRRUS? 6000 from ZEISS now enables a highly efficient and data-driven workflow for ophthalmologists, supported by the largest OCT (optical coherence tomography) reference database in the U.S. market, as well as newly enhanced cybersecurity features. As part of the ZEISS Medical Ecosystem, the latest OCT device from ZEISS, which recently received clearance by the U.S. Food and Drug Administration (FDA), helps support informed, data-driven patient PR Newswire ? 5 months ago CZMWF 0.00% CZMWY -0.49% Returns At Carl Zeiss Meditec (ETR:AFX) Appear To Be Weighed Down If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and... Simply Wall St. ? 5 months ago CZMWF 0.00% CZMWY -0.49% Carl Zeiss Meditec Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag Carl Zeiss Meditec ( ETR:AFX ) Second Quarter 2024 Results Key Financial Results Revenue: €472.1m (down 6.4% from 2Q... Simply Wall St. ? 5 months ago CZMWF 0.00% CZMWY -0.49% Declining Stock and Solid Fundamentals: Is The Market Wrong About Carl Zeiss Meditec AG (ETR:AFX)? It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has... Simply Wall St. ? 5 months ago CZMWF 0.00% CZMWY -0.49% What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate? Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a lot of attention from a... Simply Wall St. ? 6 months ago CZMWF 0.00% CZMWY -0.49% Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market Carl Zeiss Meditec AG announced today that, after securing all required regulatory approvals, it has completed the acquisition of 100% of D.O.R.C. (Dutch Ophthalmic Research Center) from the investment firm Eurazeo SE, Paris, France. The acquisition enhances and complements ZEISS Medical Technology's broad ophthalmic portfolio and range of digitally connected workflow solutions for addressing a wide variety of eye conditions, spanning retina and cornea disorders, cataract, glaucoma, and refracti PR Newswire ? 6 months ago CZMWF 0.00% CZMWY -0.49% ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024 ZEISS Medical Technology will showcase the latest in 3D visualization technology and surgical innovation at the American Society of Cataract and Refractive Surgery (ASCRS) conference from April 5-8, 2024, in Boston, MA. Building on its ZEISS Medical Ecosystem, several of the new innovations enable seamless data integration and management across the cataract and refractive workflows, creating a new standard for efficient, personalized ophthalmic care. CNW Group ? 7 months ago CZMWF 0.00% CZMWY -0.49% Carl Zeiss Meditec's (ETR:AFX) investors will be pleased with their respectable 63% return over the last five years When we invest, we're generally looking for stocks that outperform the market average. And while active stock picking... Simply Wall St. ? 7 months ago CZMWY -0.49% Performance Overview Trailing total returns as of 11/1/2024, which may include dividends or other distributions. Benchmark is DAX PERFORMANCE-INDEX Return CZMWF DAX PERFORMANCE-INDEX YTD -37.42% +14.94% 1-Year -18.50% +30.01% 3-Year -67.40% +22.73%
